Dr. Christine Munz becomes CEO at Eppendorf
August 30, 2024
Christine Munz appointed as CEO Wilhelm Plüster completes term in office as planned Hamburg – The Supervisory Board of Eppendorf SE has appointed Dr. Christine Munz as the new CEO of the Eppendorf Group. On October 1, 2024, she will succeed Dr. Wilhelm Plüster who will now take on other strategically relevant responsibilities in the [...]
August 30, 2024
TOKYO -- PHC Corporation Biomedical Division (Headquarters: Chiyoda-ku, Tokyo; President: Nobuaki Nakamura, hereinafter referred to as "Biomedical Division") will showcase a prototype of its new cell expansion system LiCellGrow at the ISCT (International Society for Cell & Gene Therapy) Europe 2024 Regional Meeting held in Gothenburg, Sweden on September 4-6. LiCellGrow, currently under development, is designed [...]
August 30, 2024
On August 5, Shimadzu Corporation signed a comprehensive partnership agreement with Shinshu University for the purpose of jointly researching solutions for challenges in society and ensuring research results are broadly adopted in society. The agreement period is 5 years. Based on the agreement, both parties will engage in searching for projects involving cutting-edge water or [...]
August 29, 2024
Promotions expand C-suite leadership as company transitions to commercial operation and commences development of large-scale single cell product pipeline. SAN DIEGO and CAMBRIDGE, England -- CS Genetics, a privately held genomics technology company, today announced the promotion of Jay Harger, PhD, to the position of Chief Operating Officer, and of Mike Stubbington, PhD, to the position of Chief Scientific Officer. In [...]
August 29, 2024
ZURICH, SWITZERLAND -- METTLER TOLEDO (NYSE: MTD) and LabWare Inc. are very pleased to announce their collaboration that introduces a new laboratory software connector. This new capability seamlessly integrates LabWare’s laboratory information management systems (LabWare LIMS®) and electronic lab notebook (LabWare ELN®) with the diverse laboratory instruments that feature the LabX™ software solution from METTLER [...]
August 29, 2024
Sapio LIMS and Sapio ELN examined on information security practices, availability, and confidentiality BALTIMORE, MD — Sapio Sciences, the science-awareTM lab informatics platform, today announced the successful completion of two key information security compliance examinations: the SOC 2 (System and Organization Controls) Type 2 examination and an attestation examination related to HIPAA/HITECH requirements, formally known as an Independent Practitioner’s Report [...]
VION Biosciences Acquires Second Asset in August, Immunoassay Development Company Ansh Labs
August 29, 2024
Acquisition drives synergy within existing VION platform and creates greater opportunity to serve diagnostic market CHARLOTTESVILLE, Va. -- VION Biosciences, a life science platform company focused on specialty materials in the life science research, diagnostic, and drug discovery spaces, announces its second acquisition this August with the acquisition of Ansh Labs, a biotechnology company that [...]
August 29, 2024
New software updates bring expanded capability to the ECLIPSE Ji smart imaging system MELVILLE, NY – Nikon Instruments Inc. (Nikon) is pleased to announce a new software update for the ECLIPSE Ji smart imaging system (compatible with NIS-Elements ver. 6.10 onward) that brings a variety of broadened experimental capabilities to areas such as oncology, neurology, and regenerative medicine. The [...]
ThinkCyte Secures $32 million in Series C Funding to Drive Global Expansion of VisionSort™
August 29, 2024
Tokyo, Japan. / Redwood City, CA -- ThinkCyte today announced the successful completion of its Series C funding round. Including the equity financing secured last November, the company raised an additional $15 million in the extension round, bringing the total to $32 million. The extension round was led by Japan Green Investment Corp. for Carbon Neutrality [...]
August 29, 2024
Under a strategic partnership with Alamar Biosciences, Biognosys is a provider of choice of NULISA multiplex assay services for biopharma research The NULISAseq™ CNS Disease and Inflammation panels are now available for customers as a contract research service from Biognosys’ high-end proteomics facility in Europe By offering the combination of NULISA affinity-based assays and TrueDiscovery® mass [...]

